Evaluating the drug-drug interactions of SHR4640 on repaglinide and midazolam in healthy subjects
2024 · Expert Opinion on Drug Metabolism & Toxicology · 0 citations
https://doi.org/10.1080/17425255.2024.2428367
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
13
Citations
2
h-index
1
i10-index
Xiaotong Hu is an academic researcher from Buchang Pharma (China). The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & Lymphoma Diagnosis and Treatment & Complement system in diseases. The author has an h-index of 2, co-authored 6 publications.
ORCID: 0009-0004-7958-4869Click to start Chat